Simultaneous Integrated Boost Intensity-Modulated Radiotherapy for Locally Advanced Drug-Resistant Gastrointestinal Stromal Tumors: A Feasibility Study

被引:1
|
作者
Li, Longhao [1 ]
Yi, Xin [1 ]
Cui, Haixia [1 ]
Zhao, Xuemei [2 ]
Dang, Jun [1 ]
Jiang, Qingfeng [1 ]
Li, Ying [1 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Oncol, Chongqing, Peoples R China
[2] Dazu Dist Peoples Hosp, Dept Oncol, Chongqing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2020年 / 10卷
关键词
gastrointestinal stromal tumors; locally advanced; drug-resistant; simultaneous integrated boost; intensity-modulated radiation therapy; RADIATION-THERAPY; GIST; MANAGEMENT; IMATINIB;
D O I
10.3389/fonc.2020.545892
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background As an emerging clinical problem, locally advanced drug-resistant gastrointestinal stromal tumors (LADRGISTs) has relatively few therapeutic schemes. Although radiotherapy is not often considered for GISTs, it could be a valuable contributing modality. The aim of our study is to explore a safe and effective radiation regimen for LADR-GISTs. Methods Three patients with LADR-GISTs were treated with simultaneous integrated boost intensity-modulated radiation therapy (SIB-IMRT) plans. In the SIB-IMRT plans, gross target volume (GTV) was divided into GTV-outer, GTV-mid, and GTV-center. And the prescribed dose of planning gross target volume (PGTV) and GTV-outer were both set to 50.4 Gy in 28 fractions. GTV-mid and GTV-center were simultaneously boosted to 60-62 Gy and 62-64 Gy respectively. For comparison purposes, conventional IMRT (Con-IMRT) plans with uniform dose distribution were generated for same optimization objectives without a dose boost to GTV-mid and GTV-center. All plans were optimized to make sure that deliver at least 95% of the prescription dose was delivered to PGTV. Isodose distribution, dose profiles, conformity indexes (CIs), monitor units (MUs), and dose volume histogram (DVH) was evaluated for each individual patient. After the three patients were treated with SIB-IMRT plans, the relative changes in the tumor size and CT values by CT scanning were also tracked. Results Compared with Con-IMRT plans, SIB-IMRT plans saw a significant increase from D-95 to D-2 of the GTV. With steeper dose gradients in the dose profiles, SIB-IMRT plans had GTV-mid and GTV-center accumulated with higher dose mainly by delivering extra 93 MUs in average. However, there was no significant difference in CIs and organs at risks (OARs) DVH. The relative changes in tumor size and CT values of the three patients in follow up were up to the Choi criteria and the three patients were all assessed as partial response. Conclusions The proposed SIB-IMRT may be a potential technique for achieving objective response and prolonging survival of selected GISTs patients.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Comorbidities and intensity-modulated radiotherapy with simultaneous integrated boost in elderly breast cancer patients
    Fiorentino, Alba
    Mazzola, Rosario
    Levra, Niccolo Giaj
    Fersino, Sergio
    Ricchetti, Francesco
    Di Paola, Gioacchino
    Gori, Stefania
    Massocco, Alberto
    Alongi, Filippo
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2018, 30 (05) : 533 - 538
  • [32] SIMULTANEOUS INTEGRATED BOOST INTENSITY-MODULATED RADIOTHERAPY IN PATIENTS WITH HIGH-GRADE GLIOMAS
    Cho, Kwan Ho
    Kim, Joo-Young
    Lee, Seung Hoon
    Yoo, Heon
    Shin, Sang Hoon
    Moon, Sung Ho
    Kim, Tae Hyun
    Shin, Kyung Hwan
    Yoon, Myonggeun
    Lee, Doo-Hyun
    Pyo, Hong Ryull
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (02): : 390 - 397
  • [33] Simultaneous Integrated Boost Intensity-Modulated Radiotherapy (SIB-IMRT) in Nasopharyngeal Cancer
    Peponi, Evangelia
    Glanzmann, Christoph
    Kunz, Guntram
    Renner, Christoph
    Tomuschat, Katja
    Studer, Gabriela
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (03) : 135 - 142
  • [34] Comorbidities and intensity-modulated radiotherapy with simultaneous integrated boost in elderly breast cancer patients
    Alba Fiorentino
    Rosario Mazzola
    Niccolò Giaj Levra
    Sergio Fersino
    Francesco Ricchetti
    Gioacchino Di Paola
    Stefania Gori
    Alberto Massocco
    Filippo Alongi
    Aging Clinical and Experimental Research, 2018, 30 : 533 - 538
  • [35] Simultaneous integrated boost intensity-modulated radiotherapy in esophageal carcinoma Early results of a phase II study
    Yu, Wei-Wei
    Zhu, Zheng-Fei
    Fu, Xiao-Long
    Zhao, Kuai-Le
    Mao, Jing-Fang
    Wu, Kai-Liang
    Yang, Huan-Jun
    Fan, Min
    Zhao, Sen
    Welsh, James
    STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (11) : 979 - 986
  • [36] Feasibility of intensity-modulated and image-guided radiotherapy for locally advanced esophageal cancer
    Nam P Nguyen
    Siyoung Jang
    Jacqueline Vock
    Vincent Vinh-Hung
    Alexander Chi
    Paul Vos
    Judith Pugh
    Richard A Vo
    Misty Ceizyk
    Anand Desai
    Lexie Smith-Raymond
    BMC Cancer, 14
  • [37] Feasibility of intensity-modulated and image-guided radiotherapy for locally advanced esophageal cancer
    Nguyen, Nam P.
    Jang, Siyoung
    Vock, Jacqueline
    Vincent Vinh-Hung
    Chi, Alexander
    Vos, Paul
    Pugh, Judith
    Vo, Richard A.
    Ceizyk, Misty
    Desai, Anand
    Smith-Raymond, Lexie
    BMC CANCER, 2014, 14
  • [38] A feasibility study of 18F-fluorodeoxyglucose positron emission tomography targeting and simultaneous integrated boost for intensity-modulated radiosurgery and radiotherapy
    Solberg, TD
    Agazaryan, N
    Goss, BW
    Dahlbom, M
    Lee, SP
    JOURNAL OF NEUROSURGERY, 2004, 101 (03) : 381 - 389
  • [39] Use of a Simultaneous Integrated Boost (SIB) in the intensity modulated Radiotherapy (IMRT) of locally advanced Head and Neck Tumors - a retrospective Analysis of Effectiveness and Toxicity
    Wichmann, J.
    Spineli, L. M.
    Durisin, M.
    Tavassol, F.
    Christiansen, H.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 : 13 - 14
  • [40] SIMULTANEOUS INTEGRATED BOOST USING INTENSITY-MODULATED RADIOTHERAPY COMPARED WITH CONVENTIONAL RADIOTHERAPY IN PATIENTS TREATED WITH CONCURRENT CARBOPLATIN AND 5-FLUOROURACIL FOR LOCALLY ADVANCED OROPHARYNGEAL CARCINOMA
    Clavel, Sebastien
    Nguyen, David H. A.
    Fortin, Bernard
    Despres, Philippe
    Khaouam, Nader
    Donath, David
    Soulieres, Denis
    Guertin, Louis
    Phuc Felix Nguyen-Tan
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (02): : 582 - 589